Keyphrases
Metformin
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Low Risk
100%
Incident Cancer
100%
New User
100%
Cancer Risk
33%
Risk Reduction
22%
AMP-activated Protein Kinase
22%
Hazard Ratio
22%
Scotland
11%
Randomized Trial
11%
Cell Growth
11%
Deprivation
11%
Tayside
11%
Cancer Diagnosis
11%
Drug Use
11%
Diabetic
11%
Blood Glucose
11%
Tumor Formation
11%
Record Linkage
11%
Observational Cohort Study
11%
High Risk
11%
Baseline Characteristics
11%
Metformin Use
11%
Median Time
11%
Diabetes Diagnosis
11%
Cancer-related
11%
Survival Analysis
11%
Cox Regression
11%
Antidiabetic Properties
11%
Medicine and Dentistry
Malignant Neoplasm
100%
Maturity Onset Diabetes of the Young
100%
Glycon
100%
Cohort Analysis
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
20%
Hazard Ratio
20%
Carcinogenesis
10%
Diabetes
10%
Antidiabetic Agent
10%
Blood Glucose
10%
Cell Growth
10%
Gene Linkage
10%
Diabetes Mellitus
10%
Body Mass Index
10%
Proportional Hazards Model
10%
Drug Use
10%
Cohort Study
10%
Survival Analysis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Metformin
100%
Cohort Study
100%
Non Insulin Dependent Diabetes Mellitus
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
20%
Carcinogenesis
10%
Antidiabetic Agent
10%
Diabetes Mellitus
10%
Biochemistry, Genetics and Molecular Biology
AMP-activated Protein Kinase
100%
Cohort Study
100%
Carcinogenesis
50%
Gene Linkage
50%
Cell Growth
50%
Glucose Blood Level
50%
Mathematics
Hazard Ratio
100%
Comparator
100%
Randomized Trial
50%
Survival Analysis
50%
Proportional Hazards Model
50%